Drugs · Entity Annotation Prototype (beta)

2articles mentioning drugs

10drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: Iscalimab ×

Iscalimab

This drug is selected. Its supporting articles are shown below.

Iscalimab2

Articles mentioning Iscalimab

2 articles · page 1 of 1

Efficacy, pharmacokinetics and safety of iscalimab (CFZ533) in patients with proliferative lupus nephritis: a randomised, double-blind, placebo-controlled, phase II study

rmdopen · abstract · 2025-08-14 · 9 matching annotations

99.0%

Iscalimab CFZ533 systemic lupus erythematosus NCT03610516 LN

…t improvement in proteinuria (UPCR) in patients with active LN. Iscalimab was generally well tolerated with the exception of a few severe…

20 Co-stimulation blockade of CD40/CD40L in SLE and beyond

lupusscimed · abstract · 2025-10-08 · 1 matching annotations

79.1%

Dapirolizumab pegol CDP7657 BI655064 CFZ533 Iscalimab systemic lupus erythematosus lupus nephritis SLE